Giants of Cancer Care® Program Inductees


George W. Sledge Jr, MD

Professor, Medicine and Oncology, and Chief of the Division of Oncology, Stanford University Medical Center

  • George W. Sledge Jr, MD, specializes in breast cancer treatment and has worked extensively to employ bioinformatics to improve the understanding and prediction of disease.
  • Dr. Sledge directed the first large nationwide study (ECOG 2100) on the use of paclitaxel to treat advanced breast cancer.
  • He has served as president of the American Society of Clinical Oncology (ASCO), as a member of the National Cancer Institute’s (NCI’s) Clinical Trials Advisory Committee, and as a member of the FDA’s Oncologic Drugs Advisory Committee.
  • As chair of the ECOG Cancer Breast Committee, he oversaw the development of several important phase III trials, including the TAILORx trial being presented at this year’s ASCO plenary session.
  • His research led to the development of CLEVER, a biomedical informatics tool that can identify distant metastatic relapse and locoregional relapse with high accuracy. Investigators will use this expanded bioinformatics approach to characterize the patterns and predictors of disease-free and overall survival among women with metastastic breast cancer. Dr. Sledge has published over 350 scientific articles spanning both laboratory and clinic.
Back to 2018 Inductees